Abstract

E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
THE CHILD DISABILITY ALLOWANCE IS USED TO SUBSIDIZE CGM IN NEW ZEALAND
Sara Mustafa1, Benjamin Wheeler2,3, Craig Jefferies4,5, Ryan Paul1,6, Lynne Chepulis1,
1University of Waikato, Division Of Health, Hamilton, New Zealand, 2University of Otago, Dunedin, New Zealand, 3Te Whatu Ora Southern, Dunedin, New Zealand, 4Starship Child Health, Auckland, New Zealand, 5The University of Auckland, Liggins Institute And Department Of Paediatrics, Auckland, New Zealand, 6Waikato Regional Diabetes Service, Te Whatu Ora Waikato, Hamilton, New Zealand
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
VARIABLES INFLUENCING THE OPTIMAL SAMPLING DURATION OF INTERMITTENTLY-SCANNED CONTINUOUS GLUCOSE MONITORING TO ASSESS 90 DAYS OF GLYCEMIA RISK INDEX. FINDINGS FROM A MULTICENTRIC REAL-WORLD STUDY
1University Hospital of Verona, Department Of Medicine - Division Of Endocrinology, Diabetes And Metabolic Diseases, Verona, Italy, 2University of Parma, Department Of Medicine And Surgery, Parma, Italy, 3ASST Papa Giovanni XXIII, Department Of Medicine - Unit Of Endocrine Diseases And Diabetology, Bergamo, Italy, 4University of Milano-Bicocca, Department Of Medicine, Milano, Italy
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
SOTAGLIFLOZIN IMPROVES TIME IN RANGE (TIR) IN PATIENTS WITH TYPE 1 DIABETES AND CHRONIC KIDNEY DISEASE
Belinda Hardin, Amy Carroll, Phillip Banks,
Lexicon Pharmaceuticals, The Woodlands, United States of America
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
ASSESSING THE EFFECTS OF CGM PREDICTIVE FEATURE USAGE ON GLYCEMIC CONTROL AND MENTAL BURDEN IN PATIENTS WITH TYPE 1 DIABETES
Anuradha Krishnan, Sydney Chanen, Trevor Bell,
dQ&A - The Diabetes Research Company, San Francisco, United States of America
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
BLOOD GLUCOSE PREDICTION IN TYPE 1 DIABETES USING A HYBRID DEEP LEARNING MODEL WITH CNN AND TRANSFORMER
Meryem Karagoz,
University of Virginia, Center For Diabetes Technology, Charlottesville, United States of America
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
FAST-ACTING INSULIN ASPART INCREASES MAINLY THE TIME IN TIGHT RANGE AMONG T1DM INDIVIDUALS USING AN AUTOMATIC INSULIN PUMP
North-Buda St. John Centrum Hospital, Internal Medicine - Diabetology Ii., Budapest, Hungary
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
LONG-TERM EFFICACY OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION OVER MORE THAN TEN YEARS IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES: A REAL-LIFE RETROSPECTIVE STUDY
University Hospital of Sain-Etienne, Endocrinology, SAINT-ETIENNE, France
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
WHAT PREDICTS MICROVASCULAR COMPLICATIONS IN TYPE 1 DIABETES? 'HIGH GLYCATION' IS NOT ASSOCIATED WITH PREVALENT RETINOPATHY OR MICROALBUMINURIA
Anna Dover, Marcus Lyall, Roland Stimson,
NHS Lothian, Edinburgh, United Kingdom
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
A COHORT STUDY INVESTIGATING THE IMPACT OF FRAILTY ON GLYCAEMIC CONTROL IN OLDER ADULTS WITH TYPE 1 DIABETES
1University Hospitals Sussex, Brighton, United Kingdom, 2University Of Exeter, Exeter, United Kingdom, 3University of Surrey, Guildford, United Kingdom
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
OVERWEIGHT AND OBESITY IN TYPE 1 DIABETES ADULTS AND CGM METRICS IN ARGENTINA
1CENDIA, Concordia, Argentina, 2CEGYM DIABETES UNIT, 1, Corrientes, Argentina, 3Cendic, Concordia, Argentina
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
EVALUATION OF USERS SATISFACTION WITH GLUCOSE MONITORING AFTER UPGRADING TO A NEW GENERATION CGM SYSTEM
Badajoz University Hospital, Endocrinología Y Nutrición, BADAJOZ, Spain
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
ACUTE EFFECTS OF DAILY LIFE SPONTANEOUS AND STRUCTURED PHYSICAL ACTIVITY ON GLYCEMIA IN CHILDREN WITH TYPE 1 DIABETES
1Univ. Lille, Univ. Artois, Univ. Littoral Côte d’Opale, ULR 7369 - URePSSS - Unité de Recherche Pluridisciplinaire Sport Santé Société, Lille, France, 2Department of Pediatrics, Lille University Hospital, Lille, France, 3Montreal Clinical Research Institute, Montréal, Canada
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
STRING ENCODING OF CGM DATA IMPROVES MEAL DETECTION
1University of Virginia, Center For Diabetes, Charlottesville, United States of America, 2University of Virginia, Charlottesville, United States of America
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
COST-EFFECTIVENESS OF A STEPPED-CARE APPORACH COMPARED TO IMMEDIATE CONTINUOUS GLUCOSE MONITORING IN HYPOGLYCEMIA-PRONE INDIVIDUALS WITH TYPE 1 DIABETES
1University Medical Center Utrecht, Vascular Medicine And Endocrinology, Utrecht, Netherlands, 2Amsterdam University Medical Center, Internal Medicine, Amsterdam, Netherlands, 3Amsterdam Public Health Research Institute, Medical Psychology, Amsterdam, Netherlands, 4Vrije Universiteit Amsterdam, Health Sciences, Faculty Of Science, Amsterdam, Netherlands
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
NEW CGM METRICS-REBOUND HIGH, REBOUND LOW, EXTENDED HIGH, EXTENDED LOW METRICS PRIOR TO SEVERE HYPOGLYCEMIA
Barbara Davis Center For Diabetes, Aurora, United States of America
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
ASSOCIATION BETWEEN TIME IN TIGHT RANGE AND RISK OF ALBUMINURIA AMONG INDIVIDUALS WITH TYPE 1 DIABETES
Ji Yoon Kim1,
1Samsung Medical Center, Division Of Endocrinology And Metabolism, Department Of Medicine, Seoul, Korea, Republic of, 2Samsung Advanced Institue for Health Sciences and Technology, Department Of Clinical Research Design And Evaluation, Seoul, Korea, Republic of
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
GLYCEMIC OUTCOMES WITH EARLY INITIATION OF CONTINUOUS GLUCOSE MONITORING SYSTEM AMONG PEDIATRIC PATIENTS WITH TYPE 1 DIABETES MELLITUS: 3-YEAR FOLLOW-UP STUDY
Hwa Young Kim,
Seoul National University Bundang Hospital, Pediatrics, Seongnam, Korea, Republic of
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
DIABETES CAMPS AS GUIDING TOOL FOR TREATMENT CHOICES
1MARMED, Diabetology, Targu Mures, Romania, 2SCJUTGM, Diabetology, Targu Mures, Romania
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
CIRCULATING PRESEPSIN LEVELS CORRELATE WITH CONTINUOUS GLUCOSE MONITORING METRICS IN INFECTION-FREE INDIVIDUALS WITH TYPE 1 DIABETES
1Aristotle University of Thessaloniki, 2nd Propedeutic Department Of Internal Medicine, Thessaloniki, Greece, 2G. Papanikolaou General Hospital, Department Of Internal Medicine, Thessaloniki, Greece, 3Aristotle University of Thessaloniki, Division Of Endocrinology And Metabolism And Diabetes Centre, First Department Of Internal Medicine, Thessaloniki, Greece
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
USING REAL WORLD EVIDENCE TO INVESTIGATE HEALTH EQUITY IN EFFECTIVENESS OF CONTINUOUS GLUCOSE MONITOR USE AMONG CHILDREN WITH TYPE 1 DIABETES
1Nationwide Children's Hospital, Department Of Pediatrics, Section Of Pediatric Endocrinology, Columbus, United States of America, 2Nationwide Children's Hospital, It Research & Innovation, Columbus, United States of America, 3Nationwide Children's Hospital, Department Of Clinical Pediatrics And Surgery, Columbus, United States of America
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
GLYCAEMIC OUTCOMES OF CONTINUOUS GLUCOSE MONITORING VIA DEXCOM IN PATIENTS WITH T1DM
Shehr Syeda1, Zahra Ravat2, Hassan Raza1, Suniva Kansakar2,
1Birmingham Heartlands Hospital, Birmingham, United Kingdom, 2Queen Elizabeth Hospital, Birmingham, United Kingdom
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
SELF-REPORTED SEVERE HYPOGLYCEMIA AFTER SWITCHING FROM REAL-TIME CGM WITH PREDICTIVE ALARMS TO INTERMITTENTLY-SCANNED CGM IN PEOPLE WITH TYPE 1 DIABETES IN SWEDEN
1Abbott Laboratories, Maidenhead, United Kingdom, 2University of Gothenburg, Sahlgrenska University Hospital And Department Of Molecular & Clinical Medicine, Gothenburg, Sweden, 3Karolinska Institute, Department Of Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden, 4Karolinska Institute, Department Of Clinical Neuroscience, Karolinska University Hospital Huddinge, Stockholm, Sweden, 5Synergus RWE AB, ÅKERSBERGA, Sweden
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
PERCENT TIME BELOW RANGE (TBR) IS STRONGLY ASSOCIATED WITH THE INCIDENCE OF CLINICALLY SIGNIFICANT LEVEL 2 OR 3 HYPOGLYCAEMIA EVENTS IN TYPE 1 DIABETES (T1D)
1Zucara Therapeutics, Toronto, Canada, 2Jaeb Center for Health Research, Tampa, United States of America, 3York University, Kinesiology And Health Sciences, Toronto, Canada, 4Yale School of Medicine, New Haven, United States of America, 5JAEB Center for Health Research, Research, Tampa, United States of America
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
GLUTEN-FREE DIET AFFECT POST-PRANDIAL GLUCOSE CONTROL IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES AND CELIAC DISEASE
1University of Verona, Department Of Surgery, Dentistry, Paediatrics And Gynaecology, Verona, Italy, 2Università degli Studi di Napoli Federico II, Naples, Italy, Department Of Translational Medical Science, Section Of Pediatrics, Naples, Italy, 3University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy, 4University of Naples Federico II, Department Of Translational Medical Science, Section Of Pediatrics, Naples, Italy, 5University and Azienda Ospedaliera Universitaria Integrata of Verona, Department Of Surgery, Dentistry, Pediatrics And Gynecology, Section Of Pediatric Diabetes And Metabolism, Verona, Italy, 6Diabetology Unit, Pediatric Clinic - S.chiara Hospital Of Trento, Trento, Italy
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
IMPROVEMENT IN NEWLY DEFINED CGM METRICS, EXTENDED HYPOGLYCEMIA AND EXTENDED HYPERGLYCEMIA WITH AUTOMATED INSULIN DELIVERY INITIATION IN PATIENTS WITH TYPE 1 DIABETES
Barbara Davis Center For Diabetes, Aurora, United States of America
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
CONTINUOUS GLUCOSE MONITORING SERVES AS A PSYCHOLOGICAL SUPPORT TOOL - INITIAL CGM IMPLEMENTATION IN ADULTS OVER 26 WITH TYPE 1 DIABETES
1Jagiellonian University Medical College, Department Of Metabolic Diseases, Kraków, Poland, 2Doctoral School of Medical Sciences and Health Sciences, Jagiellonian University Medical College, Krakow, Poland, 3Jagiellonian University Medical College, Department Of Psychiatry, Kraków, Poland, 4University of Rzeszów, College Of Medical Sciences, Rzeszów, Poland, 5University of Silesia, Department Of Internal Medicine, Diabetology And Nephrology, Faculty Of Medical Sciences In Zabrze Medical, Katowice, Poland, 6Department of Diabetology, Zagłebiowskie Centrum Onkologii, Dąbrowa Górnicza, Poland, 7Poznan University of Medical Sciences, 9. department Of Internal Medicine And Diabetology, Poznań, Poland
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
CGM DATA SHARING RELATIONSHIPS AMONG EMERGING ADULTS WITH TYPE 1 DIABETES
1Vanderbilt University Medical Center, Medicine, Nashville, United States of America, 2University of California, Merced, Merced, United States of America, 3Texas Tech university Health Sciences Center, Lubbock, United States of America, 4University of Southern California, Keck School of Medicine, Los Angeles, United States of America, 5University of Utah, Salt Lake City, United States of America
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
CHARACTERISTICS OF CGM USE AND ASSOCIATIONS WITH OUTCOMES AMONG EMERGING ADULTS WITH TYPE 1 DIABETES
1Vanderbilt University Medical Center, Medicine, Nashville, United States of America, 2Texas Tech university Health Sciences Center, Lubbock, United States of America, 3University of Utah, Salt Lake City, United States of America, 4University of Southern California, Keck School of Medicine, Los Angeles, United States of America, 5University of California, Merced, Merced, United States of America
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
PREDICTORS OF TIME IN TIGHT RANGE IN PATIENTS WITH DIABETES MELLITUS AND ADEQUATE GLYCAEMIC CONTROL: A RETROSPECTIVE STUDY FROM AN INSULIN PUMP CLINIC
1ULS São João, Endocrinology, Diabetes And Metabolism, Porto, Portugal, 2Universidade do Porto, Faculty Of Medicine, Porto, Portugal, 3ULS Viseu Dão-Lafões, Paediatrics, Viseu, Portugal, 4ULS Médio Ave, Paediatrics, Santo Tirso, Portugal, 5ULS São João, Paediatrics, Porto, Portugal
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
EXPLORING CONTINUOUS GLUCOSE MONITORING SYSTEMS IN A PEDIATRIC POPULATION
1University of Medicine and Pharmacy “Carol Davila”, Diabetes, Nutrition And Metabolic Disease, Bucharest, Romania, 2Emergency Clinical Hospital for Children “Maria Sklodowska Curie”, Diabetes, Nutrition And Metabolic Disease, Bucharest, Romania
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
METABOLOMIC PROFILE IN PATIENTS WITH TYPE 1 DIABETES WITH DIFFERENT DEGREE OF CONTROL DERIVED FROM CONTINUOUS GLUCOSE MONITORING
1Hospital Universitario Ramón y Cajal, Madrid, Spain, 2CIBERDEM, Madrid, Spain
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
EVALUATING THE EFFICACY AND HYPOGLYCEMIA RISK OF A 50% TITR TARGET IN PATIENTS WITH TYPE 1 DIABETES USING MULTIPLE DAILY INSULIN INJECTIONS
1Samsung Medical Center, Division Of Endocrinology And Metabolism, Department Of Medicine, Seoul, Korea, Republic of, 2CHUNG-ANG UNIVERSITY GWANGMYEONG HOSPITAL, Seoul, Korea, Republic of
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
AN EVALUATION OF SYSTEMATIC INTENSIVE THERAPY FOR PERSONS WITH TYPE 1 DIABETES TREATED WITH CONTINUOUS GLUCOSE MONITOIRNG (SIT-CGM) -AN RCT
1Institute of Medicine, Sahlgrenska Academy, Department Of Molecular And Clinical Medicine, Göteborg, Sweden, 2University of Gothenburg, Department Of Molecular And Clinical Medicine, Gothenburg, Sweden, 3Statistiska Konsultgruppen, Gothenburg, Sweden, 4NU Hospital Group, Department Of Medicine, Uddevalla, Sweden, 5Oslo University Hospital, Endocrinological Department, Oslo, Norway, 6Linköping University, Department Of Internal Medicine And Department Of Health, Medicine And Caring Sciences, Norrköping, Sweden, 7Sahlgrenska University Hospital, Department Of Medicine, Gothenburg, Sweden, 8Sahlgrenska Academy, University of Gothenburg, Department Of Molecular And Clinical Medicine, Gothenburg, Sweden
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
GLYCEMIC SUCCESS IN TYPE 1 DIABETES: A COMPARATIVE STUDY OF PATIENTS MEETING TIME IN RANGE VS HBA1C TARGETS
1National and Kapodistrian University of Athens Medical School, First Department Of Propaedeutic And Internal Medicine, Athens, Greece, 2National and Kapodistrian University of Athens Medical School, “Aghia Sophia” Children’s Hospital, First Department Of Pediatrics, Athens, Greece
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
DURATION OF PHYSICAL ACTIVITY REQUIRED TO AMELIORATE HYPERGLYCEMIA WITHOUT CAUSING HYPOGLYCEMIA IN TYPE 1 DIABETES
1Birmingham Women's and Children's Foundation Trust, Diabetes Home Care, Birmingham, United Kingdom, 2Jaeb Center for Health Research, Tampa, United States of America, 3York University, Kinesiology And Health Sciences, Toronto, Canada
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
GAMIFICATION TOOLS FOR LEARNING THROUGH PLAY: “TYPE 1 DIABETES EXPLORERS”
1CEGYM DIABETES UNIT, 1, Corrientes, Argentina, 2CENDIA, Concordia, Argentina, 3Hospital Pediátrico Juan Pablo II, Endocrinología Y Diabetes, Corrientes, Argentina, 4CEGYM DIABETES UNIT, 1, Corrientes Capital, Argentina, 5CENDIA, Corrientes Capital, Argentina, 6Ministerio de Salud Pública de Corrientes, Programa Provincial De Diabetes, Corrientes Capital, Argentina, 7Facultad de Medicina UBA, Dpto. De Farmacología, CABA, Argentina
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN PATIENTS OVER 80 YEARS OLD WITH TYPE 1 DIABETES
Carmen Zurera Gómez1,
1Avda. Menéndez Pidal s/n, Córdoba, Spain, 2Hospital Universitario Reina Sofia, Unidad Gestion Clínica Endocrinología Y Nutrición, Córdoba, Spain
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
INSULIN OMISSION (IO) BUT NOT EATING DISORDERS (ED) DETERIORATES CGM PROFILES IN PERSONS LIVING WITH TYPE 1 DIABETES (PWT1D)
1University Hospital Toulouse, Endocrinology And Nutrition, Toulouse, France, 2Luxembourg Institute of Health, Luxembourg, Luxembourg, 3Hôpital de la Pitié Salpêtrière - AP-HP, Paris, France, 4CH AGEN NERAC - HOPITAL SAINT-ESPRIT, Agen, France, 5CH Bretagne Atlantique, Vannes, France, 6hôpital Jean Verdier, Unité Policlinique Médicale, Bondy, France, 7CHU Clermont-Ferrand, Clermont-Ferrand, France, 8Hôpital Lariboisière - AP-HP, Paris, France, 9Hôpital Lyon Sud, Pierre Benite, France, 10hôpital Jean Verdier, Bondy, France, 11Hôpital Lariboisière, Cudc Centre Universitaire Du Diabète Et De Ses Complications, paris, France, 12CHU de Toulouse, Diabetology, Toulouse, France
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
RELATIONSHIP BETWEEN EMOTIONS AND GLYCEMIC METRICS IN PERSONS WITH TYPE 1 DIABETES
1Escuela Universitaria de Enfermería de Lugo-Santiago de Compostela University, Salud Mental Y Psiquiatría, Lugo, Spain, 2Nursery, Mental Health, Lug, Spain, 3Hospital General Universitario de Ciudad Real. Castilla- La Mancha. España, Cuidad Real, Spain, 4Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Bioestadística, Santiago de Compostela, Spain, 5Santiago de Compostela University. Faculty of Nursing, Santiago de Compostela, Spain, 6Santiago de Compostela University, Psiquiatría, Radiología, Salue Pública, Enfermería Y Medicina, Santiago de Compostela, Spain
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
THE LONGER, THE BETTER: GLYCEMIC OUTCOMES OF CHILDREN WITH TYPE 1 DIABETES WHO SPEND ON CGM 70-89% AND ≥90%
1University Hospital Motol, Department Of Pediatrics, Prague, Czech Republic, 2Faculty of Mathematics and Physics, Charles University, Department Of Probability And Mathematical Statistics, Prague, Czech Republic
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
THE VARIABILITY OF GLYCEMIC COMPLEXITY
Radboudumc, Internal Medicine, Nijmegen, Netherlands
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
IMPACT OF RECENT REAL-LIFE EXPOSURE TO HYPOGLYCEMIA ON COGNITIVE FUNCTION IN THE HYPO-RESOLVE CLAMP STUDY IN PEOPLE WITH TYPE 1 DIABETES
1Nordsjællands Hospital, Hillerød, Denmark, Endocrinology And Nephrology, Hillerød, Denmark, 2Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, Netherlands
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
AI BASED CARBOHYDRATE ESTIMATION FROM CGM DATA WITH AND WITHOUT REFERENCE CALIBRATION MEAL DATA FOR T1D PATIENTS
1MakeSense Digital Health ltd, Rishon Lezion, Israel, 2Clalit Health Services, Institute Of Diabetes Technology And Research, Herzelia, Israel, 3Eli Lilly and Company, Indianapolis, United States of America
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
THE LINK BETWEEN CGM-DERIVED GLUCOSE PARAMETERS AND CHRONIC COMPLICATIONS IN TYPE 1 DIABETES: A 5-YEAR FOLLOW-UP STUDY (GLUCOM)
Christophe De Block,
Antwerp University Hospital, Edegem, Belgium
E-Poster Viewing Topic: AS05. Continuous Glucose Monitoring (CGM) in Practice in Type 1 Diabetes
CONTINUOUS BLOOD GLUCOSE MONITORING, LEVEL OF EDUCATION AND HEALTH RELATED QUALITY OF LIFE IN ADOLESCENTS WITH TYPE 1 DIABETES DURING A THERAPEUTIC CAMP
Melinda Koródi1,
1MARMED, Diabetology, Targu Mures, Romania, 2SCJUTGM, Diabetology, Targu Mures, Romania
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
CHANGES IN CGM METRICS FOR PEOPLE WITH T2D SWITCHING FROM DULAGLUTIDE OR SEMAGLUTIDE TO TIRZEPATIDE 5MG A SUB-ANALYSIS OF THE SURPASS-SWITCH-2 STUDY
Jim Paik1, Serge Jabbour2, Brian Benneyworth1, Palash Sharma1,
1Eli Lilly and Company, Indianapolis, United States of America, 2Thomas Jefferson University, Philadelphia, United States of America, 3Northwestern University, Feinberg School Of Medicine, Chicago, United States of America
Table 1. Baseline Characteristics and Change in CGM Metrics
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
EFFECTIVENESS OF USING HYBRID CARE MODELS WITH CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES DURING RAMADAN
Hala Zakaria, Yousef Said, Milena Caccelli, Sheikha Alshehhi, Cigdem Ozkan, Judy Kattan, Hadoun Jarbi, Joelle Debs, Noah Almarzooqi, Ali Hashemi,
GluCare.Health, Dubai, United Arab Emirates
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
COST-EFFECTIVENESS OF REAL-TIME CGM IN PEOPLE WITH TYPE 2 DIABETES ON INTENSIVE INSULIN THERAPY IN ITALY
Dexcom, Inc., Global Access, Value And Evidence, San Diego, United States of America
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
EPISODIC CONTINUOUS GLUCOSE MONITORING FOR THE EVALUATION OF THE GLYCEMIC CONTROL AND HYPOGLYCEMIA OF OUTPATIENT REGIMENS IN OLDER PATIENTS WITH TYPE 2 DIABETES MELLITUS AND COMORBIDITIES
George Dafoulas1, Daphne Katsarou2, Eleni Georga3, Ioanna Drympeta4, Anastasios Alexiadis4, Ilias Kalamaras4, Konstantinos Votis4, Dimitrios Fotiadis5,
1University Of Thessaly, Department Of Endocrinology And Metabolic Diseases, Larisa, Greece, 2University of Ioannina, Dept. Of Biological Applications And Technology, Ioannina, Greece, 3University of Ioannina, Department Of Materials Science And Engineering, Ioannina, Greece., Ioannina, Greece, 4Centre of Research and Technology Hellas, Information Technologies Institute, Thessaloniki, Greece, 5University of Ioannina, Dept. Of Materials Science And Engineering, University Of Ioannina & Biomedical Research Institute, Foundation For Research And Technology, Ioannina, Greece
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
EXAMINING THE AI-DERIVED POSTPRANDIAL NORTHEAST GLUCOSE DRIFT IN INDIVIDUALS WITH OR AT RISK FOR TYPE 2 DIABETES
1NYU Grossman School of Medicine, Medicine, New York, United States of America, 2NYU Grossman School of Medicine, Population Health, New York, United States of America, 3NYU, Public Health Nutrition, New York, United States of America
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
FEASIBILITY STUDY WITH FREESTYLE-LIBRE-3 CONTINUOUS GLUCOSE MONITORING SYSTEM (CGM) IN RESIDENTIAL HOMES FOR DISABLED PEOPLE
Diabetologische Schwerpunktpraxis Bosenheim, Bad Kreuznach, Germany
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
ASSOCIATION OF FREESTYLE LIBRE CONTINUOUS GLUCOSE MONITORING UTILIZATION AND GLP-1 RECEPTOR AGONIST DISCONTINUATION: A REAL WORLD STUDY
Eileen Huang,
Abbott, Alameda, United States of America
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
DIGITAL PERSONALISED NUTRITION INTERVENTION SIGNIFICANTLY IMPROVES GLYCEMIC CONTROL IN POORLY CONTROLLED TYPE 2 DIABETES MELLITUS: REAL WORLD DATA ANALYSIS OF A 12-WEEK CGM-BASED INTERVENTION
Simone Lamme1, Parul Vats2, Linda Rodenburg2, Silke Drenth2, Myriam Schneider2, Marieke Spreeuwenberg1,
1Maastricht University, Health Services Research, Maastricht, Netherlands, 2Clear.bio, Amsterdam, Netherlands
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
ASSOCIATION BETWEEN TIME IN TIGHT RANGE AND RISK OF ALL-CAUSE MORTALITY IN PATIENTS WITH TYPE 2 DIABETES: A PROSPECTIVE COHORT STUDY
Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Department Of Endocrinology And Metabolism, Shanghai, China
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
ASSESSMENT OF GLYCEMIC PROFILES USING CONTINUOUS GLUCOSE MONITORING IN END-STAGE RENAL DISEASE PATIENTS TREATED WITH AUTOMATED PERITONEAL DIALYSIS
1Faculty of Medicine Siriraj Hospital, Mahidol University, Division Of Endocrinology And Metabolism, Department Of Medicine, Bangkok, Thailand, 2Faculty of Medicine Siriraj Hospital, Mahidol University, Siriraj Diabetes Center Of Excellence, Bangkok, Thailand, 3Faculty of Medicine Siriraj Hospital, Mahidol University, Division Of Nephrology, Department Of Medicine, Bangkok, Thailand, 4Faculty of Medicine, Thammasat University, Department Of Clinical Epidemiology And Division Of Endocrinology And Metabolism, Department Of Medicine, Prathum Thani, Thailand
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
IMPACT OF DEXCOM G7 ON GLYCEMIC CONTROL AND PATIENT SATISFACTION IN NON-INSULIN-TREATED TYPE 2 DIABETES
1Dexcom, Inc., San Diego, United States of America, 2UCSF, San Francisco, United States of America, 3York University, Kinesiology And Health Sciences, Toronto, Canada
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
OPTIMISING IMPACT OF CGM IN A RESOURCE CONSTRAINED SETTING TO IMPROVE OUTCOMES FOR INDIGENOUS PEOPLE WITH TYPE 2 DIABETES MANAGED IN PRIMARY CARE
1University of Waikato, Division Of Health, Hamilton, New Zealand, 2Hauraki Primary Healthcare Organisation, Hamilton, New Zealand, 3Health New Zealand, Hamilton, New Zealand
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
EFFECT OF IGLARLIXI IN TIME IN RANGE USING FLASH CGM IN A MEXICAN COHORT OF ADULTS WITH SUBOPTIMAL CONTROLLED TYPE 2 DIABETES
1CEMEDIN, Endocrinology, San Pedro Garza García, Mexico, 2Private practice, Endocrinology, Ciudad de México, Mexico, 3Institución privada, Guadalupe Nuevo León, Mexico, 4Hospital Clinica Nova, Research, San Nicolas de los Garza, Mexico, 5Hospital Clinica Nova, Endocrinology, San Nicolás de los Garza, Mexico
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
INTERMITTENTLY-SCANNED CGM TO MOTIVATE DIABETES SELF CARE IN LOW-INCOME BLACK WOMEN WITH T2D WHO DO NOT USE INSULIN: A PROOF OF CONCEPT STUDY
1UIC College of Nursing, Chicago, United States of America, 2UIC College of Nursing, Biobehavioral Nursing Science, Chicago, United States of America
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
USEFULNESS OF CGM TO EXPLORE GLYCEMIC PATTERNS IN TYPE 2 DIABETES PATIENTS WITH END-STAGE KIDNEY DISEASE
1Hospital Universitari Vall d' Hebron, Barcelona, Spain, 2Diverum Hemodialysis, Barcelona, Spain
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
COST-ANALYSIS OF FREESTYLE LIBRE DEVICES FROM THE NATIONAL HEALTH SYSTEM PERSPECTIVE IN PATIENTS WITH T2D ON BASAL INSULIN TREATMENT AND POOR GLYCEMIC CONTROL IN SPAIN
1Hospital General de Segovia, Endocrinology And Nutrition Unit, Segovia, Spain, 2Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain, 3Hospital Universitario de Torrecárdenas, Endocrinology And Nutrition Service, Almería, Spain, 4Hospital Universitario Virgen de la Arriaxaca, Endocrinology And Nutrition Department, Murcia, Spain, 5Centro de Salud de Cartagena Casco, Murcia, Spain, 6Hospital Universitario de Badajoz, Internal Medicine Service, Badajoz, Spain, 7Hospital Universitario Virgen del Rocío, Endocrinology And Nutrition Service, Sevilla, Spain, 8Hospital Clínico Universitario de Valencia, Endocrinology And Nutrition Department, Valencia, Spain, 9University of Valencia, Medicine Faculty, Valencia, Spain
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
THE RELATIONSHIP BETWEEN ILLNESS PERCEPTION AND CLINICAL MEASURES TO PSYCHOLOGICAL WELL-BEING AMONG TYPE 2 DIABETES PATIENTS IN THE COMMUNITY
Ruppin Academic Center, Nursing Sciences Department, Emek- Hefer, Israel
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
SELF-MANAGEMENT PRACTICES AND GLYCEMIC CONTROL AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS IN RURAL AREAS
1Universitas Swadaya Gunung Jati, Department Of Public Health, Cirebon, Indonesia, 2Universitas Swadaya Gunung Jati, Department Of Pharmacology, Cirebon, Indonesia
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
IMPACT ASSESSMENT OF CME SYMPOSIUM AT IMPROVING CLINICIANS’ KNOWLEDGE AND CONFIDENCE RELATED TO USE OF CGM IN PRACTICE
Medscape Education, Newark, United States of America
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
IMPACT OF CONTINUOUS GLUCOSE MONITORING ITSELF ON GLYCEMIC METRICS IN NON-INSULIN-TREATED TYPE2 DIABETES PATIENTS WITHOUT ANY INTERVENTIONS
Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Korea, Republic of
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
IMPACT OF FREESTYLE LIBRE 3 ON GLYCEMIC CONTROL AND ENGAGEMENT WITH DIABETES SELF-MANAGEMENT AS MEASURED BY THE IGMSS: A RANDOMIZED CONTROLLED TRIAL
Emily Soriano1, William Polonsky2, Michael Vallis3, Andrew Kwist4,
1Scripps Whittier Diabetes Institute, San Diego, United States of America, 2Behavioral Diabetes Institute, San Diego, United States of America, 3Dalhousie University, Family Medicine, Halifax, Canada, 4Abbott Laboratories, Alameda, United States of America, 5Abbott Laboratories, Maidenhead, United Kingdom
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
PREDICTORS FOR ACHIEVING GLYCEMIC TARGETS WITH CONTINUOUS GLUCOSE MONITORING IN ADULTS WITH INSULIN-TREATED TYPE 2 DIABETES - A POST HOC ANALYSIS OF THE STENO2TECH STUDY
Steno Diabetes Center Copenhagen, Clinical Research, Herlev, Denmark
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
INTEGRATION OF CONTINUOUS GLUCOSE MONITORING DYNAMICS INTO AN AI-BASED MODEL FOR THERAPEUTIC DECISION MAKING IN TYPE 2 DIABETES
1Metadvice, Precision Medicine, St-Sulpice, Switzerland, 2Inselspital, Bern University Hospital, University of Bern, Department Of Diabetes, Endocrinology, Nutritional Medicine And Metabolism, Bern, Switzerland
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
GLYCEMIC PERFORMANCE UTILIZING REAL-TIME CONTINUOUS GLUCOSE MONITORING IN CHINA: A LARGE-SCALE NATIONWIDE OBSERVATIONAL STUDY
1Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Me, Department Of Endocrinology And Metabolism, Shanghai, China, 2Shenzhen Sibionics Technology Co., Ltd, Shenzhen, China
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
INITIATING GLUCOSE MONITORING IN PERSONS WITH TYPE 2 DIABETES MELLITUS. A RANDOMIZED CONTROL TRIAL COMPARING FSL2 VS. CAPILLARY BLOOD GLUCOSE IN TERMS OF TREATMENT SATISFACTION
1Hospital de la Santa Creu i Sant Pau, Endocrinology, Barcelona, Spain, 2CIBER-DEM, Madrid, Spain, 3CIBER-BBN, Madrid, Spain
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
EFFICACY OF PERIODIC SHORT-TERM USE OF INTERMITTENTLY SCANNED CGM WITH AI-FOOD CAMERA IN NON-INSULIN-TREATED TYPE 2 DIABETES: A RANDOMIZED CLINICAL TRIAL
Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Korea, Republic of
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
EFFECTIVENESS OF SGLT2 INHIBITORS IN COMBINATION WITH INSULIN THERAPY ON METABOLIC AND GLUCOMETRIC PARAMETERS IN TYPE 2 DIABETES
University of Messina, Department Of Clinical And Experimental Medicine, Messina, Italy
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
CONTINUOUS GLUCOSE MONITORING IN CRITICALLY ILL ADULT PATIENTS: RESULTS OF A PILOT STUDY IN GREECE
1AHEPA University General Hospital, First Propaedeutic Department Of Internal Medicine, Thessaloniki, Greece, 2AHEPA University General Hospital, Intensive Care Unit, Thessaloniki, Greece, 3“Agios Pavlos” General Hospital, Intensive Care Unit, Thessaloniki, Greece, 4AHEPA University General Hospital, Department Of Anesthesia And Intensive Care, Thessaloniki, Greece, 5AHEPA University General Hospital, First Cardiology Department, Thessaloniki, Greece
Table 1. Descriptive sample statistics of sensor glucose and blood gas values.
Table 2. Differences in glycemic control depend on the glucose measurement system.
Figure 1. Scatter plot of sensor glucose and blood gas values.
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
REAL-TIME CGM USE IS ASSOCIATED WITH IMPROVED GLYCEMIC CONTROL COMPARED TO CGM NON-USERS IN COMMERCIALLY INSURED PEOPLE WITH TYPE 2 DIABETES ON SEMAGLUTIDE AND INSULIN
Dexcom, Heor, Global Access, San Diego, United States of America
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
ASSOCIATIONS BETWEEN ADHERENCE, HBA1C IMPROVEMENT AND, CONTINUOUS GLUCOSE MONITORING (CGM) BRAND IN PEOPLE WITH TYPE 2 DIABETES (PWT2D) ON BASAL INSULIN
Dexcom, Heor, Global Access, San Diego, United States of America
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
HOW THE INTRODUCTION OF CGM USE IN ADULTS WITH T2D INFLUENCES PSYCHOSOCIAL, BEHAVIORAL AND GLYCEMIC OUTCOMES
1Behavioral Diabetes Institute, San Diego, United States of America, 2Scripps Whittier Diabetes Institute, San Diego, United States of America, 3Blanchard Valley Health System, Findlay, United States of America, 4Dexcom, San Diego, United States of America
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
GLUCOSE SENSORS FOR PREGNANT WOMEN WITH TYPE 2 DIABETES - NATIONAL TRIAL WITH GLUCOSE SENSORS FOR DANISH TYPE 2 DIABETES PATIENTS
1Steno Diabetes Center, Odense University Hospital, Odense, Denmark, 2Steno Diabetes Center Aarhus, Aarhus Universityhospital, Aarhus, Denmark
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
REAL-WORLD SAFETY AND EFFICACY OF EMPAGLIFLOZIN WITH (DIAMPA-M®) OR WITHOUT METFORMIN (DIAMPA®) IN TYPE II DIABETES MELLITUS: A MULTINATIONAL, MULTI-CENTRIC POST-MARKETING SURVEILLANCE STUDY
Umar Wahab1, Mohammad Wali Naseri2, Hasibullah Mohammadi3, Charles Antonypillai4, Manilka Sumanatilleke5, Saira Sokwalla6, Catherine Gathu7, Shehzad Tahir8, Hassan Mahmood9, Mujtaba Hasan10, Jahanzeb Kamal Khan11,
1Umar Diabetes Foundation, Islamabad, Pakistan, Islamabad, Pakistan, 2Kabul University of Medical Sciences, Kabul, Afghanistan, Internal Medicine, Kabul, Afghanistan, 3Wazir Akbar Khan Hospital, Afghanistan, Endocrinology And Diabetology, Kabul, Afghanistan, 4Teaching Hospital- Kandy Sri Lanka, Kandy, Sri Lanka, 5National Hospital of Sri Lanka, Colombo, Sri Lanka, 6Agha Khan University Hospital, Nairobi, Kenya., Department Of Medicine, Nairobi, Kenya, 7Agha Khan University Hospital, Nairobi, Kenya, Nairobi, Kenya, 8Consultant Diabetologist, Rawalpindi, Pakistan, Rawalpindi, Pakistan, 9Mayo Hospital Lahore, Pakistan, Lahore, Pakistan, 10Akhtar Saeed Medical College Lahore, Lahore, Pakistan, 11College of Physicians and Surgeons Pakistan, Karachi, Pakistan, 12Shaheed Zulfikar Ali Bhutto Institute of Science and Technology, Karachi, Pakistan, Karachi, Pakistan
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
PROGRESSION OF DIABETES TREATMENT AMONG PATIENTS WITH T2DM USING FREESTYLE LIBRE-2 BLOOD GLUCOSE MONITORING SYSTEM
Prince Sultan Military Medical City, Family Medicine - Diabetes, Riyadh, Saudi Arabia
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
SHORT-TERM BENEFITS OF AN EXERCISE PRESCRIPTION WITH A NOVEL GLUCOSE BIOSENSOR ON GLYCEMIA IN MEN AND WOMEN WITH NON-INSULIN-TREATED TYPE 2 DIABETES
1York University, Kinesiology And Health Sciences, Toronto, Canada, 2Dexcom, Inc., San Diego, United States of America, 3Dexcom, San Diego, United States of America, 4Dexcom, san diego, United States of America, 5York University, Muscle Health Research Center, Toronto, Canada
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
REAL-WORLD IMPACT OF CONTINUOUS GLUCOSE MONITORING ON GLYCEMIC MANAGEMENT AND QUALITY OF LIFE IN PEOPLE WITH TYPE 2 DIABETES
Jolien De Meulemeester1,2, Evita Van Der Vorst1, Marthe Dasque1, Liesbeth Van Huffel3, Frank Nobels3, Niels Bochanen4,5, Christophe De Block4,5, Chantal Mathieu1,2, Margaretha Visser1,2, Pieter Gillard1,2,
1KU Leuven, Leuven, Belgium, 2University Hospitals Leuven, Endocrinology, Leuven, Belgium, 3OLV Hospital Aalst, Endocrinology, Aalst, Belgium, 4University of Antwerp, Antwerp, Belgium, 5Antwerp University Hospital, Endocrinology-diabetology, Edegem, Belgium
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
A FOCUS GROUP STUDY TO UNDERSTAND BARRIERS AND FACILITATORS TO CONTINUOUS GLUCOSE MONITOR (CGM) USE AMONG HISPANIC INDIVIDUALS WITH INSULIN-TREATED TYPE 2 DIABETES
Diana Soliman1, Giuliana Arevalo1, Rodolfo Galindo1, Daniel Jimenez2, Francisco Pasquel3, David Baidal1,
1University of Miami, Division Of Endocrinology, Miami, United States of America, 2University of Miami, Psychiatry And Behavioral Sciences, Miami, United States of America, 3Emory University, Atlanta, United States of America, 4University of Florida, Gainesville, United States of America
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
ASSOCIATION BETWEEN TIME IN TIGHT RANGE AND INCIDENT DIABETIC RETINOPATHY IN ADULTS WITH TYPE 2 DIABETES: A COHORT STUDY
Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Me, Department Of Endocrinology And Metabolism, Shanghai, China
E-Poster Viewing Topic: AS06. Continuous Glucose Monitoring (CGM) in Practice in Type 2 Diabetes
FEASIBILITY AND IMPACT OF CGM IN PRIMARY CARE FOR NON-INSULIN TREATED T2DM
1Danish Diabetes Association, Research & Analysis, Glostrup, Denmark, 2General Practice, Roskilde, Denmark
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
DIABETES EDUCATION THROUGH VIRTUAL REALITY IN THE METAVERSE
Hospital de León, Endocrinology, León, Spain
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
A COMBINED SYSTEM FOR DIABETES MANAGEMENT AND PREDICTION OF VARIOUS HEALTH RISKS – EXPERIENCE FROM THE WARIFA PROJECT FUNDED BY EUROPEAN UNION’S HORIZON 2020 PROGRAMME
1University of Tromsø – The Arctic University of Norway, Department Of Computer Science, Tromsø, Norway, 2Sensotrend Oy, Tampere, Finland, 3NETSUN SOFTWARE SRL, BUCURESTI, Romania
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
SYSTEMATIC REVIEW OF THE LITERATURE ON DIABETES-RELATED MOBILE APPS, A MIXED METHODS APPROACH
1Diabetes Center, National and Kapodistrian University of Athens, Athens, Greece, 2Paediatric Hospital Aglaia Kyriakou, Athens, Greece
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
THE IMPACT OF NOVEL DIGITAL THERAPEUTICS PRODUCT ON GLYCEMIC CONTROL AMONG SAUDI PATIENTS WITH DIABETES: A REAL-WORLD OBSERVATIONAL STUDY
1King Faisal Specialist Hospital & Research Center, Islet And Stem Cell Transplant Unit, Riyadh, Saudi Arabia, 2Tafdeel, Ithanin, Operations And Medical Department, Riyadh, Saudi Arabia, 3King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia, Department Of Paediatrics, Riyadh, Saudi Arabia, 4Ministry of health, Hospital Services And Specialized Centers, riyadh, Saudi Arabia, 5King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Department Of Pediatrics, Riyadh, Saudi Arabia
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
EMERGENCY TELEPHONE SERVICE FOR T1DM PATIENTS: USE, EFFECTIVENESS AND SATISFACTION
Marco Del Monte1, Giordano Spacco1, Federico Pezzotta1, Nicola Minuto2,
1University of Genova, Department Of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal And Child Health (dinogmi), Genova, Italy, 2IRCCS Istituto Giannina Gaslini, Pediatric Clinic, Genova, Italy
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
BLOOD PRESSURE REDUCTION IN A DIGITAL TYPE 2 DIABETES REMISSION PROGRAMME: 12-MONTH RESULTS FROM A REMOTE INTERVENTION
1Liva Healthcare A/S, Clinical And Research, Copenhagen, Denmark, 2Liva Healthcare A/S, Clinical And Research, London, United Kingdom
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
SELF-MANAGEMENT MOBILE APPLICATIONS FOCUSING ON IMPROVING PSYCHOLOGICAL WELLBEING AMONG PEOPLE LIVING WITH TYPE 1 DIABETES: A SYSTEMATIC REVIEW OF FEATURES, FUNCTIONS AND DATA COLLECTION APPROACHES
University of Warwick, Warwick Medical School, Coventry, United Kingdom
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
A MODEL TO ASSESS THE FINANCIAL SUSTAINABILITY OF A VIRTUAL CLINIC PROVIDING COMPREHENSIVE DIABETES CARE
1Stanford University, Stanford, United States of America, 2Northwestern University, Division Of Endocrinology, Metabolism And Molecular Medicine, Chicago, United States of America, 3International Diabetes Center, HealthPartners Institute, St Louis Park, United States of America, 4Stanford University, School Of Medicine, Palo Alto, United States of America, 5Henry Ford Health, Detroit, United States of America, 6Cecelia Health, New York, United States of America, 7Lagoon Health, Minneapolis, United States of America, 8University of Colorado School of Medicine, Aurora, United States of America, 9University of Colorado, Aurora, United States of America, 10State University of New York Upstate Medical University, Syracuse, United States of America, 11Jaeb Center for Health Research, Tampa, United States of America, 12Jaeb Center for Health Research Foundation, Inc., Tampa, United States of America
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
IMPROVEMENTS IN GLYCAEMIC CONTROL WITH A DIABETES APP: COMPARISON OF REAL-WORLD DATA WITH A RANDOMISED CONTROLLED TRIAL
1FIDAM - Research Institute Diabetes-Academy Bad Mergentheim, Bad Mergentheim, Germany, 2mySugr GmbH, Vienna, Austria, 3Roche Diabetes Care, Mannheim, Germany
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
FULL DATA TRANSMISSION (CLINICAL AND PROMS) FROM THE PATIENT'S HOME TO THE HOSPITAL TO THE NATIONAL IT-INFRASTRUCTURE AND BACK AGAIN: INDIVIDUALLY AND POPULATION-BASED
1Aalborg University, Department Of Clinical Medicine, Gistrup, Denmark, 2Aalborg University Hospital, Steno Diabetes Center North Denmark, Gistrup, Denmark
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
GIVING THE CHILD WITH DIABETES, 4-12 YEARS, A CLEAR VOICE IN OWN TREATMENT. WE REPORT ON THE FIRST PATIENT REPORTED OUTCOMES DATA FROM THE PROKIDSDIA-PROJECT
Mette Madsen1, Patricia Decosta2, Line Hasselbalch1, Lotte Vedel1, Soren Hagstrom3, Dan Grabowksi2,
1Aalborg University Hospital, Steno Diabetes Center North Denmark, Gistrup, Denmark, 2Steno Diabetes Center Copenhagen, København, Denmark, 3Aalborg University Hospital, Department Of Pediatrics, Gistrup, Denmark, 4Aalborg University, Department Of Clinical Medicine, Gistrup, Denmark
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
NON-INVASIVE ELECTROCARDIOGRAM DETERMINATION OF HBA1C
1Sts Cyril and Methodius University in Skopje, Computer Science And Engineering, Skopje, North Macedonia, 2Innovation Dooel, Data Science, Skopje, North Macedonia, 3Ss Cyril and Methodius University in Skopje, University Clinic Of Endocrinology, Skopje, North Macedonia, 4Ss Cyril and Methodius University in Skopje, University Clinic Of Cardiology, Skopje, North Macedonia
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
EVALUATING DIACTIVE-1: A PERSONALIZED MHEALTH SOLUTION FOR EXERCISE AND EDUCATION IN YOUTH WITH TYPE 1 DIABETES
1IdiSNA, Unidad Infanto Juvenil, Pamplona, Spain, 2Universidad de Las Américas, One Health Research Group, Quito, Ecuador, 3Hospital Universitario de Navarra, Endocrinología Pediátrica, Pamplona, Spain, 4Universitat de Valencia, Department Of Nursing, Valencia, Spain
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
INCIDENCE RATE AND RISK FACTORS FOR HYPOGLYCEMIA AMONG TYPE 1 DIABETES OR TYPE 2 DIABETES RECEIVING INSULIN TREATMENT IN CHINA: A PROSPECTIVE, MULTICENTER, OBSERVATIONAL STUDY
1Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China, 2Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Me, Department Of Endocrinology And Metabolism, Shanghai, China
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
THE IMPACT OF DIABETES TELE MANAGEMENT SYSTEM (DTMS®) ON REDUCING COMPLICATIONS IN TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL ANALYTICAL STUDY
1Jothydev's Diabetes Research Centre, Trivandrum, India, 2Diacare, Diabetes, Ahmadabad, India, 3Jothydev's Diabetes Research Centre, Attingal, India, 4Jothydev's Diabetes Research Centre, Kochi, India
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
A QUANTITATIVE FRAMEWORK FOR EVALUATING THE PERFORMANCE OF ALGORITHM-DIRECTED WHOLE-POPULATION REMOTE PATIENT MONITORING FOR TYPE 1 DIABETES CARE
1Stanford University School of Medicine, Division Of Endocrinology, Department Of Pediatrics, Stanford, United States of America, 2Stanford University, Management Science And Engineering, Stanford, United States of America, 3Stanford Diabetes Research Center, Stanford, United States of America, 4Clinical Excellence Research Center, Stanford, United States of America
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
ASSESSMENT OF CLINICAL PRACTICE GAPS RELATED TO KETONE MONITORING IN PEOPLE WITH DIABETES
Medscape Education, Newark, United States of America
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
CORRELATION OF LEAN MASS AND BONE DENSITY IN ELDERLY USING AI-BASED ANALYSIS OF DEXA MEASUREMENTS
Nicholas Fair1,2,
1AM Diabetes Centers of AMerica, Fitness & Wellness, Bartlett, United States of America, 2AM360 Fitness, Bartlett, United States of America, 3AM Diabetes Centers of America, Medical Director, Bartlett, United States of America, 4University of TN Health Science Center, Associate Professor, Memphis, United States of America
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
EMPOWERING PATIENTS WITH DIABETES USING PROFILING AND TARGETED FEEDBACKS DELIVERED THROUGH SMARTPHONE APP AND WEARABLE (EMPOWER): A RANDOMIZED CONTROLLED TRIAL
Jie Kie Phang1, Yu Heng Kwan1, Sungwon Yoon2, Yichi Zhang1, Hock Hai Teo3,
1SingHealth, Singapore, Singapore, 2Duke NUS Medical School, Singapore, Singapore, 3National University of Singapore, Singapore, Singapore
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
PORTABLE HARDWARE ACCELERATION FOR BLOOD GLUCOSE PREDICITION
1Universitat Politecnica de valencia, Itaca, Valencia, Spain, 2Universitat Politecnica de Valencia, Itaca, Valencia, Spain
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
BODY COMPOSITION-RELATED CARDIOMETABOLIC RISK AMONG YOUNG ADULTS WITH NEWLY DIAGNOSED TYPE 1 DIABETES - SECONDARY DATA ANALYSIS OF THE PROSPECTIVE COHORT INLIPODIAB1 STUDY
1Poznan University of Medical Sciences, Department Of Internal Medicine And Diabetology, Poznan, Poland, 2Poznan Univeristy of Medical Sciences, Unit of Medical Simulation, Department Of Medical Education, Poznań, Poland
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
DIABETES PROM INSTRUMENT (DIAPROFIL): DIFFERENCES BETWEEN TYPE 1 AND TYPE 2 DIABETES IN NORTHERN DENMARK
1Steno Diabetes Center North Denmark, Aalborg, Denmark, 2Aalborg University Hospital, Steno Diabetes Center North Denmark, Gistrup, Denmark, 3Aalborg University Hospital, Steno Diabetes Center North Denmark, Gistrup, Denmark
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
BAYESIAN CLUSTERING METHOD BASED ON RANDOM WALK MODELS TO CHARACTERIZE TEMPORAL SEQUENCES OF GLYCEMIC RISK INDEX
1University of Pavia, Department Of Electrical, Computer And Biomedical Engineering, Pavia, Italy, 2Istituti Clinici Maugeri IRCCS, Pavia, Italy, 3Institute of Pathology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
USABILITY OF AN EMOTIONAL REGULATION MOBILE APP FOR THE TREATMENT OF CHILDREN WITH TYPE 1 DIABETES
Sofia De La Villa García Roldán1,
1University of Córdoba, Psychology, Córdoba, Spain, 2Avda. Menéndez Pidal s/n, Córdoba, Spain, 3University of Salamanca, Psychology, Salamanca, Spain, 4University of Córdoba, Education, Córdoba, Spain
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
CAN YOU HEAR ME? DID YOU KNOW THERE'S A RELATIONSHIP BETWEEN DIABETES AND HEARING LOSS?
Rinker Nutritional Consulting, Waynesville, United States of America
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
THE ARGONAUT CGM PROJECT BRINGS CGM DATA TO EHRS
1Sensotrend Oy, Tampere, Finland, 2Harvard Medical School, Department Of Biomedical Informatics, Boston, United States of America, 3Microsoft, Research, Cambridge, United States of America
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
ANALYSIS OF THE IMPACT ON A DIABETES UNIT OF A REMOTE MONITORING TOOL FOR PATIENTS USING A 780G® HYBRID SYSTEM
Fatima Cuadra1, Judit Amigó2, Mònica Sànchez3, Angel Ortiz-Zuñiga3, Ana Maria Ortiz De Urbina3, Pedro Gil3,
1Vall d'Hebron Hospital, Barcelona, Spain, 2Hospital Universitari Vall d' Hebron, Barcelona, Spain, 3Hospital Universitari Vall d'Hebron, Barcelona, Spain
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
OPTIMAL BASAL INSULIN TITRATION IN TYPE 2 DIABETES: RESULTS OF THE FIRST EFFECTIVENESS AND SAFETY RANDOMIZED CONTROLLED TRIAL OF INSULTRATE - A DIGITAL TITRATION APPLICATION
1National Taiwan University Hospital, Taipei, Taiwan, 2Tri-Service General Hospital, Taipei, Taiwan, 3Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, 4Tung’s Taichung MetroHarbor Hospital, Taichung, Taiwan, 5Taipei Medical University Shuang Ho Hospital, Taipei, Taiwan, 6Chung Shan Medical University Hospital, Taichung, Taiwan, 7Sanofi, Hong Kong, Taiwan, 8National Cheng Kung University Hospital, Tainan, Taiwan
E-Poster Viewing Topic: AS07. Informatics in the Service of Medicine; Telemedicine, Software and Other Technologies
EXPLORING FEDERATED LEARNING FOR SECURE HEALTH DATA UTILIZATION ON PERSONAL DEVICES
Sungjae Jung1, Dongjae Shin1,
1Department of Biomedical Engineering, Seoul National University Hospital, Seoul, Korea, Republic of, 2Medical Bigdata Research Center, Seoul National University College of Medicine, Seoul, Korea, Republic of
E-Poster Viewing Topic: AS08. Insulin Pumps
THE IMPACT OF INSULIN DELIVERY MODALITY ON GLYCEMIC CONTROL AND FEAR OF HYPOGLYCEMIA AMONG PEOPLE WITH TYPE 1 DIABETES: A MULTICENTER STUDY FROM SAUDI ARABIA
Mohammed Al-Sofiani1,2,3,
1King Saud University, Endocrinology Unit, Riyadh, Saudi Arabia, 2King Saud University, Department Of Internal Medicine, Riyadh, Saudi Arabia, 3Division of Endocrinology, Diabetes & Metabolism, The Johns Hopkins University, Baltimore, Maryland, United States of America, 4Diabeter center, Alahsa, Saudi Arabia, 5Madinah Health Cluster, Madinah, Saudi Arabia, 6Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia, 7Department of Medicine, King Abdulaziz Medical City, King Abdullah International Research Centre, Ministry of National Guards Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia, 8College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia, 9Endocrinology section, Department of Medicine, King Abdulaziz Medical City, King Abdullah International Medical Research Centre, Ministry of National Guards Health Affairs, Jeddah, Saudi Arabia, 10Department of Internal Medicine, College of Medicine, Taibah University, Madinah, Saudi Arabia, 11King Fahad Medical City, Obesity, Endocrine And Metabolism Center, Riyadh, Saudi Arabia, 12Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, United States of America
E-Poster Viewing Topic: AS08. Insulin Pumps
HYBRID CLOSED-LOOP SYSTEM IN DIABETES; A CENTER’S EXPERIENCE
Dimitra Pappa, Eleftheria Barmpa, Anastasia-Konstantina Sakali,
University Of Thessaly, Department Of Endocrinology And Metabolic Diseases, Larisa, Greece
E-Poster Viewing Topic: AS08. Insulin Pumps
THE MINIMED™ 780G SYSTEM PROVIDES GLYCEMIC CONTROL TO BOTH FEMALES AND MALES: A REAL-WORLD ANALYSIS OF OVER 100,000 USERS
1Medtronic International Trading Sarl, Maastricht, Netherlands, 2Medtronic International Trading Sarl, Diabetes Operating Unit, Tolochenaz, Switzerland, 3Multimedica, Milan, Italy
E-Poster Viewing Topic: AS08. Insulin Pumps
EVALUATION OF SAFETY AND EFFICACY OF TWO OFF-LABEL AHCL SYSTEMS IN CHILDREN AGED LESS THAN 7 YEARS: A SINGLE CENTRE RETROSPECTIVE STUDY
Giordano Spacco1, Daniele Franzone1, Angelica Pisati1, Marco Del Monte1,
1University of Genova, Department Of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal And Child Health (dinogmi), Genova, Italy, 2IRCCS Istituto Giannina Gaslini, Pediatric Clinic, Genova, Italy
E-Poster Viewing Topic: AS08. Insulin Pumps
GLYCAEMIC CONTROL AFTER 3 MONTH OF STARTING ADVANCED HYBRID CLOSED‐LOOP (PATCH PUMP NANO TOUCHCARE SYSTEM) IN TYPE 1 DIABETES MELLITUS PATIENTS
1instituto medico rio cuarto, Endocrinología, rioc uarto, Argentina, 2instituto medico riocuarto, Endocrinologia, Rio cuarto, Argentina, 3hospital allende, cordoba, Argentina, 4DNM Min interior, BUENOS AIRES, Argentina, 5MEC, Rio cuarto, Argentina
E-Poster Viewing Topic: AS08. Insulin Pumps
IT’S LIKE LOOKING FOR A NEEDLE IN A HAYSTACK: A CASE REPORT OF A RETAINED STEEL INSULIN PUMP INFUSION SET NEEDLE
University of Naples Federico II, Department Of Translational Medical Science, Section Of Pediatrics, Naples, Italy
E-Poster Viewing Topic: AS08. Insulin Pumps
USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY
1Hospital de la Santa Creu i Sant Pau, Endocrinology Department, Barcelona, Spain, 2University of Valencia, Medicine Faculty, Valencia, Spain, 3Universidad Católica de Córdoba, Nutrition And Diabetes, Cordoba, Argentina, 4Roche Diabetes Care GmbH, Global Medical Affairs, Mannheim, Germany, 5Roche Diabetes Care Spain, S.L.U, Sant Cugat, Spain, 6Roche Diabetes Care Argentina S.A., Buenos Aires, Argentina
E-Poster Viewing Topic: AS08. Insulin Pumps
GLYCATED HEMOGLOBIN AND BETA CELL FUNCTION IMPROVED AFTER EMPAGLIFLOZIN ADDITION ON INSULIN PUMP TREATMENT IN TYPE 2 DIABETICS
Konkuk University Medical School, Internal Medicine, Chungju, Korea, Republic of
E-Poster Viewing Topic: AS08. Insulin Pumps
IMPROVED GLYCEMIC CONTROL WITH DEXCOM ONE CGM IN TYPE 1 DIABETES PATIENTS USING ACCU-CHEK SOLO MICRO PUMP: A MULTICENTER ARGENTINE STUDY
Lorena Lequi1,
1Mains Bleues, Diabetes, Rafaela, Argentina, 2Universidad Católica de Córdoba, Nutrition And Diabetes, Cordoba, Argentina
E-Poster Viewing Topic: AS08. Insulin Pumps
A REVIEW OF PATIENTS USING CONTINUOUS SUBCUTANEOUS INSULIN PUMP THERAPY (CSII) WITHIN THE NATIONAL SEVERE INSULIN RESISTANCE/LIPODYSTROPHY SERVICE (NSIRS)
1Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom, 2Cambridge University Hospitals NHS foundation Trust, Cambridge, United Kingdom
E-Poster Viewing Topic: AS08. Insulin Pumps
TUNING OPTIMIZATION FOR THE INSULET OMNIPOD 5 AMONG NEW PEDIATRIC USERS WITH TYPE 1 DIABETES
Zainab Neemuchwala1,
1University of Southern California, Quantitative And Computational Biology, Los Angeles, United States of America, 2University of Colorado Anschutz Medical Campus, Barbara Davis Center For Diabetes, Aurora, United States of America
E-Poster Viewing Topic: AS08. Insulin Pumps
GLYCEMIC CONTROL IN PEOPLE LIVING WITH TYPE 1 DIABETES USING THE MEDTRONIC MINIMED™ 780 SYSTEM: RESULTS FROM THE GALAXY SERVICE IN GREECE
1Laiko Hospital, Diabetes Center, First Department Of Propaedeutic Internal Medicine, Athens University Medical School, Athens, Greece, 2Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Second Department Of Internal Medicine, Athens, Greece, 3AHEPA University General Hospital, First Propaedeutic Department Of Internal Medicine, Thessaloniki, Greece, 4University General Hospital of Thessaloniki AHEPA, Department Of Nutrition And Dietetics, Thessaloniki, Greece, 5University General Hospital of Thessaloniki AHEPA, Diabetes Center, 1st Propaedeutic Department Of Internal Medicine, Thessaloniki, Greece
E-Poster Viewing Topic: AS08. Insulin Pumps
METRICS, SLEEP QUALITY AND HYPOGLYCEMIA AVOIDANCE BEHAVIORS IN TYPE 1 DIABETIC PATIENTS WITH DIFFERENT INSULIN THERAPIES
Eugenia Resmini, Angelo Vincenzo Cornaghi, Valentina Turra, Elena Cimino, Marco Sandri, Emanuela Zarra, Sara Madaschi, Cristina Mascadri, Bernadetta Pasquino, Giulia Massari,
ASST Spedali Civili, Brescia, Italy
E-Poster Viewing Topic: AS08. Insulin Pumps
HIGH FAT-HIGH PROTEIN TOLERANCE IN ADOLESCENTS WITH TYPE 1 DIABETES USING AUTOMATED INSULIN DELIVERY SYSTEMS- PRELIMINARY RESULTS
Yasemin Atik-Altınok1, Gunay Demir2, Emrullah Arslan3, Deniz Ozalp2, Samim Ozen2, Şükran Darcan2,
1İzmir Tınaztepe University, Faculty Of Health Sciences, Department Of Nutrition And Dietetics, Izmir, Turkey, 2Ege University, Faculty of Medicine, Department Of Pediatrics, Division Of Pediatric Endocrinology, izmir, Turkey, 3Department of Pediatric Endocrinology, Izmir City Hospital, Izmir, Turkey
E-Poster Viewing Topic: AS08. Insulin Pumps
REAL-WORLD CSII DATA OF 13,827 FRENCH T1D USERS OF A PATCH PUMP SYSTEM FROM A CLOUD-BASED DATA MANAGEMENT PLATFORM
1CHRU de Strasbourg, Service D'endocrinologie, Diabète Et Nutrition, Strasbourg, France, 2e-Health Services Sanoïa, Aubagne, France, 3Insulet France SAS, Paris, France, 4Hôpital Brabois Adultes, CHRU de Nancy et Université de Lorraine, Service D'endocrinologie, Diabetologie & Nutrition, Nancy, France
E-Poster Viewing Topic: AS08. Insulin Pumps
REAL-WORLD CSII DATA OF 934 FRENCH T2D USERS OF A PATCH PUMP SYSTEM FROM A CLOUD-BASED DATA MANAGEMENT PLATFORM
1CHRU de Strasbourg, Service D'endocrinologie, Diabète Et Nutrition, Strasbourg, France, 2e-Health Services Sanoïa, Aubagne, France, 3Insulet France SAS, Paris, France, 4Hôpital Brabois Adultes, CHRU de Nancy et Université de Lorraine, Service D'endocrinologie, Diabetologie & Nutrition, Nancy, France
E-Poster Viewing Topic: AS08. Insulin Pumps
IMPACT OF AUTOMATED INSULIN DELIVERY SYSTEMS ON GLYCEMIC CONTROL IN T1DM: A 12-MONTH RETROSPECTIVE COHORT STUDY
Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
E-Poster Viewing Topic: AS08. Insulin Pumps
TEMPORAL TRENDS AND CONTEMPORARY USE OF INSULIN PUMP THERAPY FOR PATIENTS WITH TYPE 1 DIABETES IN JAPAN
National Center for Global Health and Medicine Kohnodai Hospital, Department Of Diabetes, Endocrinology And Metabolism, Ichikawa, Chiba, Japan
E-Poster Viewing Topic: AS08. Insulin Pumps
ADVANCES IN INSULIN THERAPY FOR JAPANESE PEDIATRIC AND ADOLESCENT TYPE 1 DIABETES REVEALED BY THE 2018 COHORTS OF JSGIT
1Saitama Medical University, Department Of Pediatrics, Moroyama, Japan, 2Urakami Pediatric Endocrinology Diabetes Clinic, Tokyto, Japan, 3Abeno Medical Clinic, Osaka, Japan, 4Yokohama Rosai Hospital, Dept. Of Pediatrics, Yokohama, Japan, 5Japanese Red Cross Hokkaido College of Nursing, Division Of Clinical Medicine, Kitami, Japan, 6University of Occupational and Environmental Health, Department Of Pediatrics, Kitakyushu, Japan, 7University of Yamanashi, Dept. Of Pediatrics, Chuo, Japan, 8Yokohama City University Medical Center, Children's Medical Center, Yokomhama, Japan, 9University of Yamanashi, Dept. Of Health Sciences, Chuo, Japan, 10Tokyo Women’s Medical University, Tokyo, Japan
E-Poster Viewing Topic: AS08. Insulin Pumps
CHANGES IN BODY MASS INDEX IN PERSONS WITH TYPE 1 DIABETES MELLITUS USING THE MINIMED 780G AID SYSTEM
1Diabeter, Rotterdam, Netherlands, 2Medtronic, Maastricht, Netherlands, 3Medtronic International Trading Sarl, Diabetes Operating Unit, Tolochenaz, Switzerland
E-Poster Viewing Topic: AS08. Insulin Pumps
FIRST EXPERIENCES WITH MICROPUMPS IN BRAZIL: PILOT STUDY IN 11 ADULTS AND 5 PEDIATRIC T1PWD
Sociedade Brasileira de Diabetes, Tecnologia, Saúde Digital E Inovação, Santo André, Brazil
E-Poster Viewing Topic: AS08. Insulin Pumps
POSTPRANDIAL GLUCOSE RESPONSE TO SOLID VS. LIQUID MEALS WITH IDENTICAL MACRONUTRIENT COMPOSITION WITH AHCL SYSTEM
1Sheba Medical Center, Ramat gan, Israel, 2Sheba Medial Center, Division Of Endocrinology, Diabetes And Metabolism, Ramat Gan, Israel, 3Medtronic, Northridge, United States of America, 4Medtronic International Trading Sarl, Diabetes Operating Unit, Tolochenaz, Switzerland
E-Poster Viewing Topic: AS08. Insulin Pumps
LONG-TERM HEALTH ECONOMIC EVALUATION OF ADVANCED HYBRID CLOSED-LOOP SYSTEM COMPARED WITH ISCGM AND CSII IN A REAL-WORLD SETTING IN FINNISH INDIVIDUALS WITH TYPE 1 DIABETES
1Kuopio University Hospital, Endocrinology, Kuopio, Finland, 2Joint Municipal Authority for North Karelia Social and Health Services (Siun Sote), Internal Medicine, Joensuu, Finland, 3University of Eastern Finland, Faculty Of Medicine, Kuopio, Finland
E-Poster Viewing Topic: AS08. Insulin Pumps
REAL-LIFE GLYCEMIC OUTCOMES TWO YEARS AFTER INITIATION OF MINIMED 780G CLOSED LOOP SYSTEM IN ADULTS WITH TYPE 1 DIABETES PREVIOUSLY USING MINIMED 640G
Hospital Universitario Clínico San Carlos, Endocrinología Y Nutrición, Madrid, Spain
Table 1. Results measured by 14-day GCM.
E-Poster Viewing Topic: AS08. Insulin Pumps
FAST-ACTING INSULIN ASPART IN ADULTS USING AN ADVANCED HYBRID CLOSED LOOP SYSTEM
1Sheba Medial Center, Division Of Endocrinology, Diabetes And Metabolism, Ramat Gan, Israel, 2Medtronic, Northridge, United States of America
E-Poster Viewing Topic: AS08. Insulin Pumps
TREATMENT-INDUCED NEUROPATHY IN DIABETES POST USE OF HYBRID CLOSED LOOP CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN TYPE 1 DIABETES
Navya Basavaraju, Nichola Beard, Annmarie Jones,
The Shrewsbury and Telford Hospital NHS Trust, Diabetes & Endocrinology, Shrewsbury, United Kingdom
E-Poster Viewing Topic: AS08. Insulin Pumps
IS THERE A CORRELATION BETWEEN HYBRID CLOSED LOOP(HCL) CONTINUOUS SUBCUTANEOUS INSULIN INFUSION(CSII) GLYCAEMIC IMPROVEMENT IN TYPE 1 DIABETES(T1D) AND WORSENING SENSORINEURAL HEARING LOSS?-A CASE REPORT
Navya Basavaraju, Annmarie Jones, Victoria Wilkes,
The Shrewsbury and Telford Hospital NHS Trust, Diabetes & Endocrinology, Shrewsbury, United Kingdom
E-Poster Viewing Topic: AS08. Insulin Pumps
EFFECTS OF TECHNICAL TELEASSISTANCE PROGRAM FOR PATIENTS WITH TYPE 1 DIABETES WITH ADVANCED HYBRID SYSTEM
1Azienda Toscana Nord Ovest, Ospedale Livorno, Livorno, Italy, 2AZIENDA TOSCANA NORD OVEST, Ospedale Di Livorno, Livorno, Italy
E-Poster Viewing Topic: AS08. Insulin Pumps
HOW TO TRAIN ADOLESCENTS WITH TYPE 1 DIABETES TO USE SIMPLIFIED MEAL ANNOUNCEMENT WITH PRE-SETS OF THREE CARBOHYDRATE AMOUNTS USING MINIMED 780G?
1Sidra Medicine, Clinical Nutrition And Dietetics, Doha, Qatar, 2Sidra Medicine, Division Of Endocrinology And Diabetes, Doha, Qatar
Figure 1: HbA1c, TIR and average carbohydrate amounts per meal
E-Poster Viewing Topic: AS08. Insulin Pumps
WORSENING DIABETIC RETINOPATHY WITH 6 YEAR FOLLOW-UP OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY
1ROYAL DERBY HOSPITAL, Ophthalmology, DERBY, United Kingdom, 2University Hospitals of Derby and Burton NHS Foundation Trust, Department Of Diabetes And Endocrinology, Derby, United Kingdom
E-Poster Viewing Topic: AS08. Insulin Pumps
DESCRIPTIVE STUDY ON THE EVOLUTION OF GLYCEMIC CONTROL AFTER INITIATION OF THE MINIMED 780G HYBRID CLOSED-LOOP SYSTEM IN ADULTS WITH TYPE 1 DIABETES MELLITUS (T1DM)
Hospital Universitario Clínico San Carlos, Endocrinología Y Nutrición, Madrid, Spain
E-Poster Viewing Topic: AS08. Insulin Pumps
GLYCEMIC CONTROL ACHIEVED BY MINIMED 780G USERS WITH SELF-REPORTED TYPE 2 DIABETES IS SUSTAINABLE FOR AT LEAST 6 MONTHS: A REAL-WORLD ANALYSIS ON 862 USERS
1Medtronic International Trading Sarl, Diabetes Operating Unit, Tolochenaz, Switzerland, 2Medtronic, Maastricht, Netherlands, 3Caen University Hospital, Diabetes Care Unit, Caen, France, 4University of Bari Aldo Moro, Milan, Italy
E-Poster Viewing Topic: AS08. Insulin Pumps
EFFECTS OF INITIATING SENSOR AUGMENTED PUMP THERAPY ON DIABETES DISTRESS IN PEOPLE WITH TYPE 1 DIABETES
University Clinical centre of Serbia, Clinic For Endocrinology, Diabetes And Metabolic Diseases, Belgrade, Serbia
E-Poster Viewing Topic: AS08. Insulin Pumps
TRANSFORMATIVE IMPACT OF HYBRID ADVANCED CLOSED-LOOP INSULIN DELIVERY SYSTEMS ON TYPE 1 DIABETES MANAGEMENT IN PATIENTS WITH COMPLEX PSYCHIATRIC COMORBIDITIES: A CASE SERIES
1Centre hospitalier du Nord, Endocrinology, Ettelbrück, Luxembourg, 2University of Luxembourg, Fstm, Esch-sur-Alzette, Luxembourg
E-Poster Viewing Topic: AS08. Insulin Pumps
MANAGEMENT OF MILD AND MODERATE DIABETIC KETOACIDOSIS USING ADVANCED HYBRID CLOSED-LOOP SYSTEMS: CASE REPORTS OF THE MEDTRONIC 780G INSULIN PUMP
Centre hospitalier du Nord, Endocrinology, Ettelbrück, Luxembourg
E-Poster Viewing Topic: AS09. New Insulin Delivery Systems: Inhaled, Transderma, Implanted Devices
RAPID INSULIN KINETICS FOLLOWING BOLUS INTO VASCULARIZED MICROCHAMBERS IMPLANTED SUBCUTANEOUSLY IN DIABETIC PIGS
University of Arizona, Department Of Surgery, Tucson, United States of America
E-Poster Viewing Topic: AS10. New Insulins
MICRO-AMOUNTS OF GLUCAGON PREMIXED IN FAST-ACTING INSULIN (LYUMJEV®); EFFECT ON INSULIN ABSORPTION AND GLUCOSE CONSUMPTION
NTNU, Trondheim, Norway
E-Poster Viewing Topic: AS10. New Insulins
REAL-WORLD EFFECTIVENESS AND SAFETY OF IGLARLIXI IN ADULTS WITH TYPE 2 DIABETES IN GULF COUNTRIES: A SUB-ANALYSIS OF SUCCESS STUDY
1My Clinic International, Jeddah, Saudi Arabia, 2Erfan & Bagedo Hospital, Jeddah, Saudi Arabia, 3Nahdi Care Clinic, Jeddah, Saudi Arabia, 4Dallah Hospital, Riyadh, Saudi Arabia, 5New Mowasat Hospital, Kuwait, Kuwait, 6Dubai Diabetes Center, Dubai, United Arab Emirates, 7Sanofi, Jeddah, Saudi Arabia, 8Sanofi, Dubai, United Arab Emirates, 9Dar Alshifa Hospital, Hawalli, Kuwait
E-Poster Viewing Topic: AS10. New Insulins
EFSITORA VS. DEGLUDEC IN INSULIN-NAÏVE ADULTS WITH TYPE 2 DIABETES (QWINT-2)
Carol Wysham1, Harpreet Bajaj2, Stefano Del Prato3, Denise Franco4, Arihiro Kiyosue5, Dominik Dahl6, Chunmei Zhou7, Molly C. Carr7, Michael Case7,
1Rockwood Clinic, Spokane, United States of America, 2LMC Healthcare, Ontario, Canada, 3Sant’ Anna School of Advanced Studies in Pisa, Pisa, Italy, 4CPCLIN Clinical Research Center, Sao Paulo, Brazil, 5Tokyo-eki Center Building Clinic, Tokyo, Japan, 6Gemeinschaftspraxis fur Innere Medizin und Diabetologie, Hamburg, Germany, 7Eli Lilly and Company, Indianapolis, United States of America
E-Poster Viewing Topic: AS10. New Insulins
LOWER GLYCAEMIC VARIABILITY AND DEGLUDEC THERAPY ARE PROTECTIVE AGAINST ONSET OF HYPOGLYCAEMIA IN TYPE 1 DIABETES AND LADA
1Clinical Hospital Merkur, Vuk Vrhovac University Clinic, Zagreb, Croatia, 2General Hospital Virovitica, Virovitica, Croatia, 3University of Zagreb, Zagreb, Croatia
E-Poster Viewing Topic: AS10. New Insulins
INSULIN INITIATION AND ADHERENCE BEHAVIOURS: A CROSS-SECTIONAL SURVEY OF PEOPLE WITH TYPE 2 DIABETES AND HEALTHCARE PROVIDERS IN INDIA
1Madras Diabetes Research Foundation & Dr. Mohan's Diabetes Specialities Centre, Diabetology, Chennai, India, 2Bharti Research Institute of Diabetes & Endocrinology, Karnal, India, 3CARE Hospital, Hyderabad, India, 4Chellaram Hospital Diabetes Care & Multispecialty, Prune, India, 5Medica Superspeciality Hospital, Kolkata, India, 6Gini Health, Shivalik Hospital, Sahibzada Ajit Singh Nagar, India, 7Novo Nordisk India Pvt Ltd, Bengaluru, India
E-Poster Viewing Topic: AS10. New Insulins
THE EFFICACY AND SAFETY OF SWITCHING FROM RAPID-ACTING INSULINS TO ULTRA-RAPID INSULIN LISPRO IN TYPE 1 DIABETES USING CONTINUOUS GLUCOSE MONITORING: A REAL-WORLD STUDY
1University Hospital Antwerp, Diabetology-endocrinology, Edegem, Belgium, 2Vitaz, Diabetology-endocrinology, Sint-Niklaas, Belgium, 3AZ Klina, Diabetology-endocrinology, Brasschaat, Belgium, 4AZ Rivierenland, Diabetology-endocrinology, Bornem, Belgium
E-Poster Viewing Topic: AS10. New Insulins
EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML IN ELDERLY PEOPLE WITH TYPE 2 DIABETES: AN OBSERVATIONAL STUDY (ELDERLY-T)
1Practice for Endocrinology, Diabetes and Obesity, Baslerstrasse 30, CH-4600, Olten, Switzerland, 2MVZ Metabolic Medicine Leipzig Endocrinology Practice, Leipzig, Germany, 3Division of Cardiology, Angiology, Pneumology, Center of Internal Medicine, University of Heidelberg, Heidelberg, Germany, 4Sanofi, Berlin, Germany, 5sanofi, Vernier, Switzerland, 6Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center – University of Freiburg, Freiburg, Germany
E-Poster Viewing Topic: AS10. New Insulins
PATIENT-REPORTED OUTCOMES (PROS) IN ELDERLY PEOPLE WITH TYPE 2 DIABETES USING INSULIN GLARGINE 300 U/ML (ELDERLY-T STUDY)
1Practice for Endocrinology, Diabetes and Obesity, Baslerstrasse 30, CH-4600, Olten, Switzerland, 2MVZ Metabolic Medicine Leipzig Endocrinology Practice, Prager Str. 34, DE-04317, Leipzig, Germany, 3Division of Cardiology, Angiology, Pneumology, Center of Internal Medicine, University of Heidelberg, Heidelberg, Germany, 4Sanofi, Berlin, Germany, 5Sanofi, Vernier, Switzerland, 6Division of Endocrinology and Diabetology, Department of Medicine II, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
E-Poster Viewing Topic: AS10. New Insulins
INSULIN TREATMENT SIMPLIFICATION WITH IGLARLIXI IN RELATIVELY WELL-CONTROLLED PATIENTS WITH TYPE 2 DIABETES
1Békés County Central Hospital, 1st Department Of Endocrinology, Békéscsaba, Hungary, 2University of Debrecen, Division Of Endocrinology, Department Of Internal Medicine, Faculty Of Medicine, Debrecen, Hungary, 3University of Szeged, Department Of Internal Medicine, Szeged, Hungary
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
DEVELOPMENT OF NONINVASIVE DIABETES MANAGEMENT METHOD USING GLYCATED ALBUMIN IN TEARS
1The University of Tokyo, Faculty Of Medicine, Tokyo, Japan, 2Kumamoto University, School Of Medicine, Tokyo, Japan
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
COMBINATION OF ICOVAMENIB AND GLP-1-BASED THERAPEUTIC AGENTS IMPROVES BETA CELL FUNCTION AND INSULIN SECRETION
1Biomea Fusion Inc., San Carlos, United States of America, 2Biomea Fusion, Redwood City, United States of America
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
ETHNICITY-SPECIFIC CHANGES IN HBA1C AND USE OF GLUCOSE-LOWERING THERAPIES FOLLOWING INITIATION OF SGLT2I AND/OR GLP1RA
1University of Waikato, Division Of Health, Hamilton, New Zealand, 2Midlands Health Network, Hamilton, New Zealand, 3Procare Health Limitd, Auckland, New Zealand, 4University of Auckland, Faculty Of Medical And Health Sciences, Auckland, New Zealand, 5Te Whatu Ora Counties/Te Toka Tumai Auckland, Auckland, New Zealand, 6Northcare Medical Centre, Hamilton, New Zealand, 7Waikato Regional Diabetes Service, Te Whatu Ora Waikato, Hamilton, New Zealand
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
CARDIO-HEPATIC PROTECTIVE EFFECTS OF THE DIPEPTIDYL PEPTIDASE-4 INHIBITOR AND GLYCAEMIA IMPROVEMENT IN ADOLESCENTS WITH TYPE 1 DIABETES AND NON-ALCOHOLIC STEATOHEPATITIS: A RANDOMIZED CONTROLLED CLINICAL TRIAL
1Faculty of Medicine, Ain Shams University, Department Of Pediatrics, Cairo, Egypt, 2Faculty of Medicine, Ain Shams University, Department Of Clinical Pathology, Cairo, Egypt
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
ADIPONECTIN/LEPTIN RATIO INCREASE AFTER ENAVOGLIFLOZIN TREATMENT IN PATIENTS WITH TYPE 2 DIABETES
1Hanyang University Guri Hospital, Division Of Endocrinology, Department Of Internal Medicine, Guri-si, Gyeonggi-do, Korea, Republic of, 2Chosun University Hospital, Gwangju, Korea, Republic of, 3Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Korea, Republic of
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
EFFECTS OF GLP-1 MEDICATIONS ON LEAN MASS INDEX, FAT MASS INDEX, VISCERAL FAT, AND APPENDICULAR LEAN MASS INDEX IN TYPE 2 DIABETES PATIENTS
Nicholas Fair1,2,
1AM Diabetes Centers of America, Fitness & Wellness, Bartlett, United States of America, 2AM360 Fitness, Bartlett, United States of America, 3AM Diabetes Centers of America, Medical Director, Bartlett, United States of America, 4University of TN Health Science Center, Associate Professor, Memphis, United States of America
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
IMPROVED GLYCEMIC CONTROL IN TYPE 1 DIABETES PATIENTS CARRYING HLA DR3-DQ2: FURTHER INSIGHTS FROM CONTINUOUS GLUCOSE MONITORING FROM THE PHASE 2B DIAGNODE-2 TESTING RHGAD65
1Diamyd Medical AB, Stockholm, Sweden, 2OneTwo Analytics, Stockholm, Sweden
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
PUTTING THE ADA STANDARDS OF MEDICAL CARE IN DIABETES INTO PRACTICE: HOW TO IMPLEMENT THE RECOMMENDATIONS
Rinker Nutritional Consulting, Waynesville, United States of America
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
TESTOSTERONE REPLACEMENT THERAPY IMPROVES GLYCAEMIC CONTROL AND SYMPTOMS OF HYPOGONADISM IN MEN WITH TYPE 2 DIABETES – THE ABCD WORLDWIDE AUDIT
Hugh Jones1, Karim Haider2, Ahmed Haider2, Umesh Dashora3,
1Barnsley Hospital NHSFT, Diabetes And Endocrinology, Barnsley, United Kingdom, 2Praxis Dr.Haider, Urology, Bremerhaven, Germany, 3Conquest Hospital, Diabetes And Endocrinology, Hastings, United Kingdom, 4City Hospital, Diabetes, Birmingham, United Kingdom
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
LOW-DOSE GLUCAGON AFTER FASTED EXERCISE FOLLOWING LOW VS. HIGH CARBOHYDRATE DIETS – A THREE-ARM RANDOMIZED CROSSOVER STUDY
1Steno Diabetes Center Copenhagen, Herlev, Denmark, 2NovoNordisk Center for Basic Metabolic Research, Copenhagen, Denmark, 3Health Technology and Solutions Interdisciplinary Research Institute, Faculty Of Science And Engineering, Swansea, United Kingdom, 4Steno Diabetes Center Copenhagen, Diabetes Technology Research, Herlev, Denmark
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
SODIUM GLUCOSE CO-TRANSPORTER2 (SGLT2) INHIBITOR FOR MANAGEMENT OF REFRACTORY HYPOMAGNESEMIA IN MATURITY-ONSET DIABETES OF THE YOUNG TYPE 5 (MODY5)
1Vimut-Theptarin Hospital, Diabetes, Thyroid, And Endocrine Center, BANGKOK, Thailand, 2Vimut-Theptarin Hospital, Diabetes, Thyroid, And Endocrine Center, New York, Thailand
E-Poster Viewing Topic: AS11. New Medications for Treatment of Diabetes
ONLINE MEDICAL EDUCATION ADVANCES PHYSICIANS’ KNOWLEDGE ABOUT THE EVOLUTION OF INCRETIN-BASED THERAPIES IN HOLISTIC DIABETES MANAGEMENT
1WebMD Health Corp, Medscape Education, London, United Kingdom, 2University Hospitals of Leicester NHS Trust, Diabetes Research Unit, Leicester, United Kingdom
E-Poster Viewing Topic: AS12. Screening for and Prevention of Type 1 Diabetes
SCREENING FOR PRESYMPTOMATIC TYPE 1 DIABETES IN FIRST-DEGREE RELATIVES: A SINGLE-CENTER EXPERIENCE
Hospital Infantil Universitario Niño Jesús, Endocrinology, Madrid, Spain
E-Poster Viewing Topic: AS12. Screening for and Prevention of Type 1 Diabetes
PERFORMANCE OF A NEW PROTOTYPE ELISA FOR THE DETECTION OF AUTOANTIBODIES AGAINST GAD 65 IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
Skander Elleuche1, Gia-Gia Hò1, Alexander Kühnl1, Malgorzata Baranowska-Dell2, Kai Masur3,4, Petra Augstein5,
1Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany, 2Department of General, Visceral, Thoracic, and Vascular Surgery, Research Group of Predictive Diagnostics, University Medical Center Greifswald, Greifswald, Germany, 3Leibniz Institute for Plasma Science and Technology (INP Greifswald), Greifswald, Germany, 4Diabetes Competence Centre Karlsburg (KDK), Karlsburg, Germany, 5Department for Diabetology, Klinikum Karlsburg, Heart and Diabetes Center Karlsburg, Karlsburg, Germany
E-Poster Viewing Topic: AS12. Screening for and Prevention of Type 1 Diabetes
EVALUATION OF A NEW PROTOTYPE ELISA FOR THE DETECTION OF AUTOANTIBODIES AGAINST IA2 IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
Skander Elleuche1, Gia-Gia Hò1, Alexander Kühnl1, Malgorzata Baranowska-Dell2, Kai Masur3,4, Petra Augstein5,
1Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany, 2Department of General, Visceral, Thoracic, and Vascular Surgery, Research Group of Predictive Diagnostics, University Medical Center Greifswald, Greifswald, Germany, 3Leibniz Institute for Plasma Science and Technology (INP Greifswald), Greifswald, Germany, 4Diabetes Competence Centre Karlsburg (KDK), Karlsburg, Germany, 5Department for Diabetology, Klinikum Karlsburg, Heart and Diabetes Center Karlsburg, Karlsburg, Germany
E-Poster Viewing Topic: AS12. Screening for and Prevention of Type 1 Diabetes
ADDRESSING BARRIERS TO TYPE 1 DIABETES MANAGEMENT: INSIGHTS FROM AN EXPLORATORY DESIGN PROCESS IN TANZANIA
1Medtronic Labs, Nairobi, Kenya, 2Tanzania Diabetes Association(TDA), Dar es salaam, Tanzania, 3Medtronic Labs, Dar es Salaam, Tanzania, 4Medtronic Labs, Clinical, Strategy And Innovation, Nairobi, Kenya
E-Poster Viewing Topic: AS12. Screening for and Prevention of Type 1 Diabetes
HEMOGLOBIN GLYCATION INDEX: A USEFUL TOOL IN TYPE 1 DIABETES PATIENT’S FOLLOW-UP?
1Hospitals of the University of Coimbra, Endocrinology, Coimbra, Portugal, 2Coimbra University, Faculty Of Medicine, Coimbra, Portugal
E-Poster Viewing Topic: AS12. Screening for and Prevention of Type 1 Diabetes
CASE REPORT: THE PSYCHOLOGICAL IMPACT OF TYPE 1 DIABETES SCREENING ON PARENTS
1University of Campania, Naples, Italy, 2University of Campania L. Vanvitelli, Pediatric Diabetology “g.stoppoloni”, Napoli, Italy
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
ASSESSING SOCIODEMOGRAPHIC DISPARITIES IN WEIGHT LOSS OUTCOMES: IMPLICATIONS FOR TAILORED DIGITAL HEALTH INTERVENTIONS IN LIVA’S 9-MONTH DIABETES PREVENTION PROGRAMME
Katrine Kaslund1,
1University of Copenhagen, Public Health, Copenhagen, Denmark, 2Liva Healthcare A/S, Clinical And Research, Copenhagen, Denmark, 3Liva Healthcare A/S, Clinical And Research, London, United Kingdom
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
A BETA PANCREATIC METHYLATION BIOSIGNATURE FOR THE DIAGNOSIS & PREDICTION OF TYPE 2 DIABETES MELLITUS
Makrina Karaglani1,2, Maria Panagopoulou1,2, Gesthimani Tarapatzi2, Ioanna Panagiota Kalafati3, Theodosios Theodosiou2, Konstantinos Arvanitidis2, Ioannis Tsamardinos4,5,6, Georgios Dedoussis3,
1Institute of Agri-Food and Life Sciences, Hellenic Mediterranean University Research Centre, Heraklion, Greece, 2Democritus University of Thrace, Alexandroupoli, Greece, 3Harokopio University of Athens, Athens, Greece, 4Department of Computer Science, Hraklion, Greece, 5JADBio Gnosis DA S.A, STEP-C, Heraklion, Greece, 6Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, Heraklion, Greece, 7ABCureD P.C, Alexandroupoli, Greece
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
NON-INVASIVE NEAR-INFRARED SYSTEM FOR SCREENING FOR DIABETES: THE RESULTS FROM ANODE03
Päivi Maria Paldánius1,
1University of Helsinki, Helsinki, Finland, 2Institut Català de la Salut, Barcelona, Spain, 3Glyconics Ltd, Basingstoke, United Kingdom, 4Teslar Consulting, Chippenham, Wiltshire, United Kingdom, 5Hospital de la Santa Creu i Sant Pau, Endocrinology, Barcelona, Spain
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS
Päivi Maria Paldánius1, John Salter2, M Elena Hernandez3, Berta Tipo4, Josep Franch4,
1University of Helsinki, Helsinki, Finland, 2Teslar Consulting, Chippenham, Wiltshire, United Kingdom, 3CAP Besos, Barcelona, Spain, 4CAP Drassanes, Barcelona, Spain, 5Institut Català de la Salut, Barcelona, Spain, 6Hospital de la Santa Creu i Sant Pau, Endocrinology, Barcelona, Spain
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
MACHINE LEARNING DIAGNOSTIC MODELS OF PREDIABETES AND TYPE 2 DIABETES USING CONTINUOUS GLUCOSE MONITORING DATA -
University of Padova, Department Of Information Engineering, Padova, Italy
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
THE IMPACT OF AGE AND SEX ON FASTING PLASMA GLUCOSE AND GLYCATED HAEMOGLOBIN (HBA1C) IN THE NON-DIABETES POPULATION
1University of Manchester, Manchester, United Kingdom, 2Res Consortium, Andover, United Kingdom, 3The Benchmarking Partnership, Keele, United Kingdom, 4Addenbrookes Hospital, Biochemistry, Cambridge, United Kingdom, 5Keele University, Keele, United Kingdom
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
MEASURING THE COMORBIDITY BURDEN OF DIABETES AND ITS DETERMINANTS IN THE EUROPEAN UNION USING A COMPREHENSIVE COMORBIDITY INDEX
University of Debrecen, Department Of Public Health And Epidemiology, Debrecen, Hungary
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
CERAMIDES SURPASS LDL-CHOLESTEROL IN PREDICTING CARDIOVASCULAR MORTALITY IN DIABETIC AND NON-DIABETIC PATIENTS
1Private University in the Principality of Liechtenstein, Triesen, Liechtenstein, 2Vorarlberg Institute for Vascular Investigation & Treatment (VIVIT), Feldkirch, Austria, 3Academic Teaching Hospital Feldkirch, Feldkirch, Austria, 4Zora Biosciences, Espoo, Finland, 5Medical Central Laboratories, Feldkirch, Austria
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
ONSITE SCREENINGS IN THE WORKPLACE FOR EARLY DETECTION OF DIABETES AND PREDIABETES IN RURAL MISSISSIPPI USING DCA VANTAGE A1C MACHINES
1Tallahatchie General Hospital Medical Foundation, Wellness | Mississippi Diabetes Network, Charleston, United States of America, 2William Carey University College of Osteopathic Medicine, Charleston, United States of America
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
ASSOCIATION OF TRANSCRIPTION FACTOR 7-LIKE 2 (TCF7L2) GENE POLYMORPHISM RS7895340 AS A RISK FACTOR FOR TYPE 2 DIABETES MELLITUS IN JAVANESE POPULATION
1Universitas Swadaya Gunung Jati, Departement Of Genetics, Cirebon, Indonesia, 2Universitas Swadaya Gunung Jati, Genetics, Cirebon, Indonesia
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
COMBINED MUTATIONS OF KCNJ11 AND PPARΓ GENE POLYMORPHISMS IN TYPE 2 DIABETES MELLITUS PATIENTS
Universitas Swadaya Gunung Jati, Genetics Departement, Cirebon, Indonesia
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
ENZYMATIC DETECTION OF ALPHA-HYDROXYBUTYRATE AS A CLINICAL BIOMARKER FOR EARLY DIAGNOSIS OF INSULIN RESISTANCE
DirectSens GmbH, Vienna, Austria
E-Poster Viewing Topic: AS13. Screening for and Prevention of Type 2 Diabetes
DIFFERENT PHENOTYPES OF GESTATIONAL DIABETES INFLUENCE METABOLIC ABNORMALITIES IN NORMOGLYCEMIC WOMEN POSTPARTUM
1University Clinical centre of Serbia, Clinic For Endocrinology, Diabetes And Metabolic Diseases, Belgrade, Serbia, 2Clinical Center of Serbia, Belgrade, Serbia
E-Poster Viewing Topic: AS14. Glucose Monitoring and Advanced Medical Technologies Used in Hospitals
COMPARISON OF CONTINUOUS GLUCOSE MONITORING CGM-BASED COMPOSITE METRICS FOR ASSESSMENT OF GLYCEMIC STATUS IN IN-PATIENT DIABETES CARE
1Klinikum Karlsburg, Karlsburg, Germany, 2Institute of Diabetes “Gerhardt Katsch”, Karlsburg, Germany, 3Institute of Diabetes, Karlsburg, Germany, 4selbständiger wissenschaftlicher Berater, Pirna, Germany, 5Biomedical Informatics Consultants LLC, Clinical Biostatistics, Potomac, United States of America
E-Poster Viewing Topic: AS14. Glucose Monitoring and Advanced Medical Technologies Used in Hospitals
EFFICACY AND SAFETY OF THE MINIMED 780G® ADVANCED HYBRID CLOSED-LOOP SYSTEM IN PERIOPERATIVE MANAGEMENT OF PATIENTS WITH TYPE 1 DIABETES
1Pontificia Universidad Javeriana, Bogota, Colombia, 2Pontificia Universidad Javeriana, bogota, Colombia
E-Poster Viewing Topic: AS14. Glucose Monitoring and Advanced Medical Technologies Used in Hospitals
GREATER SAFETY AND EFFICACY OF INSULIN DEGLUDEC/LIRAGLUTIDE COMPARED TO MDI IN THE TRANSITION FROM HOSPITAL TO OUTPATIENT MANAGEMENT IN T2D, EVALUATED BY CONTINUOUS GLUCOSE MONITORING
Ana María Gómez1,2,
1Pontificia Universidad Javeriana, Bogota, Colombia, 2Hospital Universitario San Ignacio, Bogota, Colombia
